Vice Health and Wellness Inc (Z24.MU)
| Previous close | 0.0050 |
| Open | 0.0050 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0050 - 0.0050 |
| 52-week range | 0.0010 - 0.0570 |
| Volume | |
| Avg. volume | 693 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireVice Health and Wellness Using AI to Change the Way We Lose Weight and Manage Addiction
NEW YORK, NY, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Vice Health and Wellness Inc. (Vice) (CSE: VICE) (OTC Pink: VICFF) is embracing artificial intelligence (AI) and cutting-edge nutraceutical technology to strategically position itself to become a global leader in the health and wellness industry. More specifically, Vice is developing an AI-driven proprietary platform that will act as a “companion” to provide users with the necessary tools for a more personalized, sustainable, and supported weight
PR NewswireVICE UPDATES DEVELOPMENT OF PROPRIETARY ARTIFICIAL INTELLIGENCE APP FOR OBESTIY, WEIGHT-LOSS AND ADDICTION
Vice Health and Wellness Inc. ("Vice" or the "Company") (CSE: VICE) (FSE: Z24) (OTC: VICFF) is thrilled to announce a substantial progress update on its newly formed, 100% owned and proprietary, Vice Versa AI (initial news release August 17, 2023). This purpose-built app is poised to redefine weight loss and addiction management.
PR NewswireVice Health and Wellness Signs Letter of Intent to Advance Scientific Technology Solutions for Weight Loss and Obesity
Vice Health and Wellness Inc. (CSE: VICE) (FSE: Z24) (OTC Pink: VICFF) is excited to announce the signing of a Letter of Intent ("LOI") with Biologic Pharmamedical Research Ltd to initiate a collaborative product research and development partnership for weight-loss and obesity focused products. The purpose of the LOI is to express mutual interest in developing cutting-edge nutraceutical technology products that aim to revolutionize health categories through effective and science-based innovation
